| 今开：6.11 | 昨收：6.14 |
| 最高：6.33 | 最低：5.9 |
| 涨停价： | 跌停价： |
| 总市值：6.4875594E7 |
Lantern Pharma(LTRN)02-29 10:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-028948 Act: 33 Size: 5 KB 网页链接查看全文
Lantern Pharma(LTRN)02-29 10:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-028949 Act: 33 Size: 5 KB 网页链接查看全文
Lantern Pharma(LTRN)05-03 19:35
$Lantern Pharma(LTRN)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-017626 Act: 34 Size: 2 MB 网页链接查看全文
Lantern Pharma(LTRN)02-29 10:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-028950 Act: 33 Size: 5 KB 网页链接查看全文
Lantern Pharma(LTRN)04-27 09:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053231 Act: 33 Size: 10 KB 网页链接查看全文
Lantern Pharma(LTRN)04-27 09:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053230 Act: 33 Size: 10 KB 网页链接查看全文
Lantern Pharma(LTRN)05-10 04:15
$Lantern Pharma(LTRN)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001493152-24-018426 Act: 34 Size: 9 MB 网页链接查看全文
牛股小红书2022-01-13 10:55
$Lantern Pharma(LTRN)$ 宣布扩大与美国国立卫生研究院（National Institutes of Health）国家癌症研究所（NCI）的合作协议。
公司表示，这项合作的扩大是在确定了几个基因特征之后进行的，这些基因特征预测了患者肿瘤对Lantern的候选药物LP-184和LP-284的潜在反应。
LP-184作为一种新的...查看全文
$Lantern Pharma(LTRN)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001493152-24-018426 Act: 34 Size: 9 MB 网页链接
$Lantern Pharma(LTRN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-018422 Act: 34 Size: 3 MB 网页链接
$Lantern Pharma(LTRN)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-017626 Act: 34 Size: 2 MB 网页链接
$Lantern Pharma(LTRN)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-016840 Act: 34 Size: 924 KB 网页链接
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053230 Act: 33 Size: 10 KB 网页链接
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053229 Act: 33 Size: 9 KB 网页链接
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053232 Act: 33 Size: 9 KB 网页链接
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053231 Act: 33 Size: 10 KB 网页链接
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053228 Act: 33 Size: 10 KB 网页链接
$Lantern Pharma(LTRN)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001493152-24-010303 Act: 34 Size: 8 MB 网页链接